Parp1 Localizes within the Dnmt1 Promoter and Protects Its Unmethylated State by Its Enzymatic Activity

Background Aberrant hypermethylation of CpG islands in housekeeping gene promoters and widespread genome hypomethylation are typical events occurring in cancer cells. The molecular mechanisms behind these cancer-related changes in DNA methylation patterns are not well understood. Two questions are particularly important: (i) how are CpG islands protected from methylation in normal cells, and how is this protection compromised in cancer cells, and (ii) how does the genome-wide demethylation in cancer cells occur. The latter question is especially intriguing since so far no DNA demethylase enzyme has been found. Methodology/Principal Findings Our data show that the absence of ADP-ribose polymers (PARs), caused by ectopic over-expression of poly(ADP-ribose) glycohydrolase (PARG) in L929 mouse fibroblast cells leads to aberrant methylation of the CpG island in the promoter of the Dnmt1 gene, which in turn shuts down its transcription. The transcriptional silencing of Dnmt1 may be responsible for the widespread passive hypomethylation of genomic DNA which we detect on the example of pericentromeric repeat sequences. Chromatin immunoprecipitation results show that in normal cells the Dnmt1 promoter is occupied by poly(ADP-ribosyl)ated Parp1, suggesting that PARylated Parp1 plays a role in protecting the promoter from methylation. Conclusions/Significance In conclusion, the genome methylation pattern following PARG over-expression mirrors the pattern characteristic of cancer cells, supporting our idea that the right balance between Parp/Parg activities maintains the DNA methylation patterns in normal cells. The finding that in normal cells Parp1 and ADP-ribose polymers localize on the Dnmt1 promoter raises the possibility that PARylated Parp1 marks those sequences in the genome that must remain unmethylated and protects them from methylation, thus playing a role in the epigenetic regulation of gene expression.

[1]  M. Zampieri,et al.  Epigenetics: poly(ADP‐ribosyl)ation of PARP‐1 regulates genomic methylation patterns , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Zlatanova,et al.  CCCTC-binding factor: to loop or to bridge , 2009, Cellular and Molecular Life Sciences.

[3]  G. Zupi,et al.  CCCTC-binding Factor Activates PARP-1 Affecting DNA Methylation Machinery , 2008, Journal of Biological Chemistry.

[4]  W. Reik,et al.  Safeguarding parental identity: Dnmt1 maintains imprints during epigenetic reprogramming in early embryogenesis. , 2008, Genes & development.

[5]  R. Jaenisch,et al.  Maternal and zygotic Dnmt1 are necessary and sufficient for the maintenance of DNA methylation imprints during preimplantation development. , 2008, Genes & development.

[6]  W. Kraus Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. , 2008, Current opinion in cell biology.

[7]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[8]  M. Szyf The role of dna hypermethylation and demethylation in cancer and cancer therapy , 2008, Current Oncology.

[9]  W. Kraus,et al.  Reciprocal Binding of PARP-1 and Histone H1 at Promoters Specifies Transcriptional Outcomes , 2008, Science.

[10]  G. Felsenfeld,et al.  We gather together: insulators and genome organization. , 2007, Current opinion in genetics & development.

[11]  T. Mikkelsen,et al.  Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites , 2007, Proceedings of the National Academy of Sciences.

[12]  Michael Q. Zhang,et al.  Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome , 2007, Cell.

[13]  M. Fraga,et al.  Epigenetic disruption of ribosomal RNA genes and nucleolar architecture in DNA methyltransferase 1 (Dnmt1) deficient cells , 2007, Nucleic acids research.

[14]  E. Li,et al.  Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells , 2007, Nature Genetics.

[15]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[16]  Yun-Fai Chris Lau,et al.  Erratum to “The poly(ADP-ribose) polymerase 1 interacts with Sry and modulates its biological functions” [Mol. Cell Endocrinol. 257–258 (2006) 35–46] , 2007, Molecular and Cellular Endocrinology.

[17]  Yun-Fai Chris Lau,et al.  The poly(ADP-ribose) polymerase 1 interacts with Sry and modulates its biological functions , 2006, Molecular and Cellular Endocrinology.

[18]  Rolf Ohlsson,et al.  CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Francastel,et al.  Accumulation of small murine minor satellite transcripts leads to impaired centromeric architecture and function. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Fraga,et al.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.

[21]  W. Reik,et al.  How imprinting centres work , 2006, Cytogenetic and Genome Research.

[22]  S. Baylin,et al.  DNA methylation and gene silencing in cancer , 2005, Nature Clinical Practice Oncology.

[23]  K. Robertson DNA methylation and human disease , 2005, Nature Reviews Genetics.

[24]  M. Zampieri,et al.  DNA methylation and chromatin structure: The puzzling CpG islands , 2005, Journal of cellular biochemistry.

[25]  M. Zampieri,et al.  Modulation of DNMT1 activity by ADP-ribose polymers , 2005, Oncogene.

[26]  R. Ohlsson,et al.  Poly(ADP-ribosyl)ation and Epigenetics: Is CTCF PARt of the Plot? , 2005, Cell cycle.

[27]  Rolf Ohlsson,et al.  Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation , 2004, Nature Genetics.

[28]  J. Minna,et al.  RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. , 2004, Cancer research.

[29]  Michèle Rouleau,et al.  Poly(ADP-ribosyl)ated chromatin domains: access granted , 2004, Journal of Cell Science.

[30]  C. Simbulan-Rosenthal,et al.  PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase , 2003, Oncogene.

[31]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[32]  M. Hottiger,et al.  Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1* , 2003, Journal of Biological Chemistry.

[33]  Eva K. Lee,et al.  Predicting aberrant CpG island methylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Satoshi Tanaka,et al.  Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways. , 2003, Nucleic acids research.

[35]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[36]  R. Jaenisch,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.

[37]  C. Kanduri,et al.  The nucleotides responsible for the direct physical contact between the chromatin insulator protein CTCF and the H19 imprinting control region manifest parent of origin-specific long-distance insulation and methylation-free domains. , 2003, Genes & development.

[38]  Daiya Takai,et al.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R Ohlsson,et al.  CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. , 2001, Trends in genetics : TIG.

[40]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[41]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[42]  G. Zardo,et al.  Inhibition of poly(ADP‐ribosyl)ation introduces an anomalous methylation pattern in transfected foreign DNA , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  G. Zardo,et al.  Reduced levels of poly(ADP‐ribosyl)ation result in chromatin compaction and hypermethylation as shown by cell‐by‐cell computer‐assisted quantitative analysis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  G. Zardo,et al.  The Unmethylated State of CpG Islands in Mouse Fibroblasts Depends on the Poly(ADP-ribosyl)ation Process* , 1998, The Journal of Biological Chemistry.

[45]  R. Strom,et al.  Does poly(ADP-ribosyl)ation regulate the DNA methylation pattern? , 1997, Biochemistry.

[46]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[47]  M. Robert,et al.  DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.

[48]  S. Tilghman,et al.  CTCF maintains differential methylation at the Igf2/H19 locus , 2003, Nature Genetics.

[49]  A. Bird DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[50]  Matthew Tudor,et al.  Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation , 2001, Nature Genetics.